Lv4
480 积分 2024-09-06 加入
Identification of childhood-onset lupus nephritis through integrative bioinformatics: otoferlin as a novel biomarker
1小时前
待确认
ARL8B promotes hepatocellular carcinoma progression and inhibits antitumor activity of lenvatinib via MAPK/ERK signaling by interacting with RAB2A
14天前
已完结
DeepZ: A Deep Learning Approach for Z-DNA Prediction
15天前
已完结
Transposable elements are driving rapid adaptation of Enterococcus faecium
22天前
已完结
Cancer‐Associated Fibroblasts Promote Tumor Immunosuppression in Hepatocellular Carcinoma via the NNMT‐ANGPTL4 Axis
24天前
已完结
Improving surgical treatments for hepatocellular carcinoma
1个月前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study
1个月前
已完结
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial
1个月前
已完结
Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions
1个月前
已完结
The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment
1个月前
已完结
皖公网安备34019202002308
